Jane Street
DRUG

Jane Street’s Bright Minds Biosciences DRUG Stock Holding History

Jane Street’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Hold
6,400
– – ﹤0.01% 8279
2026
Q1 		$467K Sell
6,400
-2,618
-29% -$211K ﹤0.01% 8222
2025
Q4 		$704K Sell
9,018
-6,885
-43% -$460K ﹤0.01% 6948
2025
Q3 		$965K Buy
+15,903
New +$617K ﹤0.01% 6386
2025
Q2 		– Sell
-6,600
Closed -$238K – 9876
2025
Q1 		$238K Hold
6,600
– – ﹤0.01% 8187
2024
Q4 		$238K Buy
+6,600
New +$232K ﹤0.01% 8123
2024
Q3 		– Sell
-10,937
Closed -$11.8K – 9717
2024
Q2 		$11.8K Sell
10,937
-2,858
-21% -$3.22K ﹤0.01% 9092
2024
Q1 		$16.6K Buy
+13,795
New +$24.2K ﹤0.01% 8914
2022
Q4 		– Sell
-3,865
Closed -$24K – 9321
2022
Q3 		$24K Sell
3,865
-1,075
-22% -$6.97K ﹤0.01% 9149
2022
Q2 		$20K Hold
4,940
– – ﹤0.01% 9157
2022
Q1 		$37K Buy
+4,940
New +$55.4K ﹤0.01% 9777

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jane Street's DRUG Position: Q2 2026 in Review

Jane Street held its Bright Minds Biosciences (DRUG) position steady in Q2 2026 at 6,400 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #8279.

Jane Street first reported a position in DRUG in Q1 2022 and has held it in 11 quarters since. The position peaked at $965K in Q3 2025. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Jane Street held 6,400 shares of Bright Minds Biosciences worth $449K as of Q2 2026.
  • Jane Street left its Bright Minds Biosciences share count unchanged in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8279 holding.
  • Jane Street first reported a position in Bright Minds Biosciences in Q1 2022 and has held it in 11 quarters since.
  • Jane Street's Bright Minds Biosciences position peaked at $965K in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.